Roy A. Mariuzza

Roy A. Mariuzza's AcademicInfluence.com Rankings

Roy A. Mariuzza

Biology

#11174

World Rank

#14552

Historical Rank

Immunology

#719

World Rank

#741

Historical Rank

Biochemistry

#1820

World Rank

#1958

Historical Rank

biology Degrees

Download Badge

Biology

Roy A. Mariuzza's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry University of California, Berkeley

Why Is Roy A. Mariuzza Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roy A. Mariuzza's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution (1986) (1054)
Bound water molecules and conformational stabilization help mediate an antigen-antibody association. (1994) (448)
Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. (2002) (361)
Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition. (2004) (351)
The structural basis of T cell activation by superantigens. (1999) (326)
Standard nomenclature for the superantigens expressed by Staphylococcus. (2004) (296)
Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand (1999) (291)
Three-dimensional structure of an antigen–antibody complex at 6 Å resolution (1985) (290)
Crystal structure of a T-cell receptor β-chain complexed with a superantigen (1996) (280)
Crystal structure of the beta chain of a T cell antigen receptor. (1995) (254)
Molecular recognition in antibody-antigen complexes. (2002) (239)
Structure of a human autoimmune TCR bound to a myelin basic protein self‐peptide and a multiple sclerosis‐associated MHC class II molecule (2005) (199)
The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure (1986) (192)
Three-Dimensional Structure of the Complex between a T Cell Receptor β Chain and the Superantigen Staphylococcal Enterotoxin B (1998) (182)
Crystal Structure of the Vα Domain of a T Cell Antigen Receptor (1995) (175)
Molecular basis of antigen mimicry by an anti-idiotope (1995) (166)
Sedimentation velocity analysis of heterogeneous protein-protein interactions: Lamm equation modeling and sedimentation coefficient distributions c(s). (2005) (161)
Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. (1991) (161)
The structural basis of antigen-antibody recognition. (1987) (160)
Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin- derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition (1992) (154)
A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. (1998) (152)
X-ray snapshots of the maturation of an antibody response to a protein antigen (2003) (150)
A Mutational Analysis of the Binding of Staphylococcal Enterotoxins B and C3 to the T Cell Receptor β Chain and Major Histocompatibility Complex Class II (1998) (148)
Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2Kb (2003) (141)
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. (2001) (141)
Peptidoglycan recognition proteins of the innate immune system. (2007) (138)
A mutational analysis of the binding of two different proteins to the same antibody. (1996) (136)
Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. (2000) (136)
The Cell Wall Lipid PDIM Contributes to Phagosomal Escape and Host Cell Exit of Mycobacterium tuberculosis (2017) (135)
Three‐dimensional structure determination of an anti‐2‐phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response. (1990) (134)
Crystal structure of a complete ternary complex of T-cell receptor, peptide–MHC, and CD4 (2012) (128)
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. (2002) (126)
Studying multiprotein complexes by multisignal sedimentation velocity analytical ultracentrifugation. (2005) (125)
Superantigen binding to a T cell receptor beta chain of known three- dimensional structure (1995) (124)
Structural basis for peptidoglycan binding by peptidoglycan recognition proteins. (2004) (120)
High-affinity lamprey VLRA and VLRB monoclonal antibodies (2009) (114)
Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6 (2011) (114)
Binding specificity of multiprotein signaling complexes is determined by both cooperative interactions and affinity preferences. (2004) (113)
Structure of the Vδ domain of a human γδ T-cell antigen receptor (1998) (107)
Structure of a lamprey variable lymphocyte receptor in complex with a protein antigen (2009) (105)
Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria. (2003) (101)
Cis interactions of immunoreceptors with MHC and non-MHC ligands (2008) (101)
Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. (2009) (100)
The structure of the T cell antigen receptor. (1996) (98)
Dual strategies for peptidoglycan discrimination by peptidoglycan recognition proteins (PGRPs). (2006) (98)
Antigen recognition by human γδ T cells: pattern recognition by the adaptive immune system (2009) (97)
MHC class I molecules, structure and function. (1999) (96)
Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,). (2000) (96)
Molecular Basis of the Dual Functions of 2B4 (CD244)1 (2008) (95)
TCR recognition of peptide/MHC class II complexes and superantigens. (2007) (94)
Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. (2000) (94)
Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens. (2017) (94)
Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization. (1990) (93)
Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. (2009) (91)
Structural basis for the recognition of mutant self by a tumor-specific, MHC class II–restricted T cell receptor (2007) (89)
Crystal structure of human peptidoglycan recognition protein S (PGRP-S) at 1.70 A resolution. (2005) (86)
Structural Features of Nonpeptide Prenyl Pyrophosphates That Determine Their Antigenicity for Human γδ T Cells1 (2001) (86)
Structure of a TCR with high affinity for self‐antigen reveals basis for escape from negative selection (2011) (84)
Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. (1998) (83)
Binding of the Natural Killer Cell Inhibitory Receptor Ly49A to Its Major Histocompatibility Complex Class I Ligand (2002) (83)
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. (1996) (81)
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. (1998) (81)
High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. (2001) (80)
The multiple mechanisms of T cell receptor cross-reactivity. (2009) (80)
So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes. (2002) (80)
Role of the T Cell Receptor α Chain in Stabilizing TCR-Superantigen-MHC Class II Complexes (1999) (80)
Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies. (1995) (77)
Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins (2007) (76)
Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. (2000) (75)
Crystal Structure of Imaginal Disc Growth Factor-2 (2002) (75)
The basics of binding: mechanisms of antigen recognition and mimicry by antibodies. (1993) (75)
Structural basis of MHC class I recognition by natural killer cell receptors (2001) (73)
Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells. (2000) (73)
Structural basis for self‐recognition by autoimmune T‐cell receptors (2012) (72)
Structural and Biophysical Insights into the Role of CD4 and CD8 in T Cell Activation (2013) (71)
Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions. (2000) (71)
Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen. (2003) (70)
Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. (2009) (70)
A structural basis for antigen recognition by the T cell-like lymphocytes of sea lamprey (2010) (66)
Crystal structure of an Fv-Fv idiotope-anti-idiotope complex at 1.9 A resolution. (1996) (66)
Role of the T Cell Receptor Ligand Affinity in T Cell Activation by Bacterial Superantigens* (2001) (66)
Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3 (1998) (65)
Analysis of binding interactions in an idiotope-antiidiotope protein-protein complex by double mutant cycles. (1997) (64)
Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. (2006) (64)
Structure of the F‐spondin domain of mindin, an integrin ligand and pattern recognition molecule (2009) (64)
Conservation of Nonpeptide Antigen Recognition by Rhesus Monkey Vγ2Vδ2 T Cells1 (2003) (63)
Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody* (2015) (63)
Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design (2016) (62)
Redundancy in Antigen-Presenting Function of the HLA-DR and -DQ Molecules in the Multiple Sclerosis-Associated HLA-DR2 Haplotype1 (2006) (61)
Preliminary crystallographic study of the complex between the Fab fragment of a monoclonal anti-lysozyme antibody and its antigen. (1983) (60)
The structural basis of T-cell receptor (TCR) activation: An enduring enigma (2019) (59)
Selective Recognition of Synthetic Lysine and meso-Diaminopimelic Acid-type Peptidoglycan Fragments by Human Peptidoglycan Recognition Proteins Iα and S* (2005) (59)
Molecular Architecture of the Major Histocompatibility Complex Class I-binding Site of Ly49 Natural Killer Cell Receptors* (2008) (58)
Structural Basis for Recognition of Cellular and Viral Ligands by NK Cell Receptors (2014) (56)
Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces. (2005) (55)
Multiple paths to multispecificity. (2006) (55)
Three-dimensional structure and thermodynamics of antigen binding by anti-lysozyme antibodies. (1993) (55)
The effect of water activity on the association constant and the enthalpy of reaction between lysozyme and the specific antibodies D1.3 and D44.1 (1996) (54)
Insights into the Structural Basis of Antibody Affinity Maturation from Next-Generation Sequencing (2018) (53)
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in mice (2016) (53)
Functional Analysis of the TCR Binding Domain of Toxic Shock Syndrome Toxin-1 Predicts Further Diversity in MHC Class II/Superantigen/TCR Ternary Complexes 1 (2003) (53)
Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. (2007) (52)
Sugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans. (2013) (51)
Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida (2018) (51)
Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. (2007) (51)
Crystal Structure of the C-terminal Peptidoglycan-binding Domain of Human Peptidoglycan Recognition Protein Iα* (2004) (50)
Structure‐function studies of T‐cell receptor‐superantigen interactions (1998) (48)
Structure and function of the T-cell receptor: insights from X-ray crystallography. (1996) (48)
Crystal Structure of Staphylococcal Enterotoxin I (SEI) in Complex with a Human Major Histocompatibility Complex Class II Molecule* (2006) (47)
Solvent rearrangement in an antigen-antibody interface introduced by site-directed mutagenesis of the antibody combining site. (1994) (46)
Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4–HLA-DR1 complex (2011) (46)
Dissecting Cooperative and Additive Binding Energetics in the Affinity Maturation Pathway of a Protein-Protein Interface* (2003) (45)
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells (2019) (45)
A novel loop domain in superantigens extends their T cell receptor recognition site. (2007) (45)
Superantigen recognition by gammadelta T cells: SEA recognition site for human Vgamma2 T cell receptors. (2001) (45)
Hydrogen bonding and solvent structure in an antigen-antibody interface. Crystal structures and thermodynamic characterization of three Fv mutants complexed with lysozyme. (1996) (44)
Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule. (2006) (43)
Structural insights into the editing of germ-line–encoded interactions between T-cell receptor and MHC class II by Vα CDR3 (2012) (43)
Crystal structure of the murine cytomegalovirus MHC-I homolog m144. (2005) (42)
Crystal structure of human peptidoglycan recognition protein Iα bound to a muramyl pentapeptide from Gram‐positive bacteria (2006) (41)
Peptide–MHC (pMHC) binding to a human antiviral T cell receptor induces long-range allosteric communication between pMHC- and CD3-binding sites (2018) (40)
Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells. (2010) (40)
Structural basis of affinity maturation and intramolecular cooperativity in a protein-protein interaction. (2005) (40)
T cell receptor bias for MHC: co-evolution or co-receptors? (2014) (39)
Characterization of anti-anti-idiotypic antibodies that bind antigen and an anti-idiotype. (1997) (38)
Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. (2002) (38)
Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. (1999) (37)
Quantifying the energetics of cooperativity in a ternary protein complex. (2002) (37)
Identification of the Docking Site for CD3 on the T Cell Receptor β Chain by Solution NMR* (2015) (37)
Exploration of the P6/P7 Region of the Peptide-binding Site of the Human Class II Major Histocompatability Complex Protein HLA-DR1* (2003) (37)
Crystal structure of the complex of the variable domain of antibody D1.3 and turkey egg white lysozyme: a novel conformational change in antibody CDR-L3 selects for antigen. (1996) (36)
Recognition of the Thomsen-Friedenreich Pancarcinoma Carbohydrate Antigen by a Lamprey Variable Lymphocyte Receptor* (2013) (36)
Come Together (2001) (34)
Cis–trans interactions of cell surface receptors: biological roles and structural basis (2011) (34)
Mapping the Ligand of the NK Inhibitory Receptor Ly49A on Living Cells (2000) (34)
Variable dimerization of the Ly49A natural killer cell receptor results in differential engagement of its MHC class I ligand. (2006) (34)
Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope* (2015) (33)
Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. (2003) (33)
Minor structural changes in a mutated human melanoma antigen correspond to dramatically enhanced stimulation of a CD4+ tumor-infiltrating lymphocyte line. (2002) (32)
Structural basis for differential recognition of tyrosine‐phosphorylated sites in the linker for activation of T cells (LAT) by the adaptor Gads (2004) (31)
Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. (2001) (31)
MHC class I recognition by Ly49 natural killer cell receptors. (2002) (31)
Structural insights into the evolution of the adaptive immune system. (2013) (31)
Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen (2020) (29)
Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor. (1998) (29)
Selection of the lamprey VLRC antigen receptor repertoire (2014) (29)
Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells. (2003) (29)
Structure of NKp65 bound to its keratinocyte ligand reveals basis for genetically linked recognition in natural killer gene complex (2013) (28)
A Response Calculus for Immobilized T Cell Receptor Ligands* (2001) (27)
Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease (2013) (27)
Crystal structure of the V alpha domain of a T cell antigen receptor. (1995) (26)
Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope (2017) (25)
Protein motion and lock and key complementarity in antigen-antibody reactions. (1995) (23)
Secretion of a homodimeric V alpha C kappa T-cell receptor-immunoglobulin chimeric protein. (1989) (23)
Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T‐cell receptor Vβ8.2 (2007) (23)
Cloning, expression and interaction of human T-cell receptors with the bacterial superantigen SSA. (2004) (23)
Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome. (2012) (22)
Structure-Based Design of Altered MHC Class II–Restricted Peptide Ligands with Heterogeneous Immunogenicity (2013) (22)
N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity. (2021) (21)
Assessing energetic contributions to binding from a disordered region in a protein-protein interaction . (2010) (21)
Uptake and Intracellular Trafficking of Superantigens in Dendritic Cells (2013) (21)
Structural and physicochemical analysis of the reaction between the anti‐lysozyme antibody D1.3 and the anti‐idiotopic antibodies E225 and E5.2 (1994) (21)
Structure of the saccharide-binding domain of the human natural killer cell inhibitory receptor p75/AIRM1. (2004) (20)
Mapping the Energy of Superantigen Staphylococcus Enterotoxin C3 Recognition of an α/β T Cell Receptor Using Alanine Scanning Mutagenesis (2000) (20)
Structural Basis for Recognition of the T Cell Adaptor Protein SLP-76 by the SH3 Domain of Phospholipase Cγ1 (2005) (20)
Structural insights into the evolution of the adaptive immune system: the variable lymphocyte receptors of jawless vertebrates (2010) (19)
Dual conformations of a T cell receptor V alpha homodimer: implications for variability in V alpha V beta domain association. (1997) (19)
BETA CHAIN OF A T CELL ANTIGEN RECEPTOR (1995) (18)
Chemical basis for diversity in antibody specificity analysed by hapten binding to monoclonal anti-4-hydroxy-3-nitrophenacetyl (NP) immunoglobulins. (1981) (18)
Supramolecular assembly of Toll-like receptor 7/8 agonist into multimeric water-soluble constructs enables superior immune stimulation in vitro and in vivo. (2020) (17)
Crystallization and Preliminary X-ray Diffraction Study of a Bacterially Produced T-cell Antigen Receptor Vα Domain (1994) (17)
Crystal structure of human peptidoglycan recognition protein I alpha bound to a muramyl pentapeptide from Gram-positive bacteria. (2006) (16)
Three-dimensional structure and antigen binding specificity of antibodies. (1990) (16)
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors (2022) (15)
Preliminary crystallographic study of the Fab fragment of a monoclonal anti-phenylarsonate antibody. (1983) (15)
Appendix. Purification, molecular weight, and NH2-terminal sequence of cystathionine gamma-synthase of Escherichia coli. (1983) (15)
The oldest antibodies newly discovered (2008) (14)
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization (2020) (14)
Crystal structure of a peptidoglycan recognition protein (PGRP) in complex with a muramyl tripeptide from Gram-positive bacteria (2005) (14)
Preliminary crystallographic study of the Fab fragments of two monoclonal anti-2-phenyloxazolone antibodies. (1985) (13)
Structure and Thermodynamics of Antigen Recognition by Antibodies a (1995) (13)
The Interaction with H-2Dd in cis is Associated with a Conformational Change in the Ly49A NK Cell Receptor (2011) (13)
The energetics of antigen-antibody binding. (1994) (13)
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer (2021) (13)
Imperfect interfaces (1998) (13)
NMR structure of the natural killer cell receptor 2B4 (CD244): implications for ligand recognition. (2005) (12)
Crystal Structure of Staphylococcal Enterotoxin G (SEG) in Complex with a Mouse T-cell Receptor β Chain* (2010) (12)
Crystals of the human heavy chain disease protein Riv and human Fc fragment are isomorphous: further evidence for conformational flexibility in the hinge region of immunoglobulins. (1983) (12)
In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly. (2020) (12)
Entropically Assisted Carbohydrate Recognition by a Natural Killer Cell‐Surface Receptor (2004) (11)
Structural basis for recognition of the T cell adaptor protein SLP-76 by the SH3 domain of phospholipase Cgamma1. (2005) (11)
Faculty Opinions recommendation of Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding. (2018) (11)
Crystallization and Preliminary X-ray Diffraction Analysis of the β-Chain of a T-cell Antigen Receptor (1994) (11)
Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30. (2016) (10)
Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs). (2020) (9)
Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody. (2015) (9)
Crystallization of the fab fragments of monoclonal anti-p-azophenylarsonate antibodies and their complexes with haptens. (1984) (9)
Activity Augmentation of Amphioxus Peptidoglycan Recognition Protein BbtPGRP3 via Fusion with a Chitin Binding Domain (2015) (8)
Crystallization of antibody fragments and their complexes with antigen (1988) (8)
Expression, crystallization and preliminary crystallographic analysis of the extracellular IgV-like domain of the human natural killer cell inhibitory receptor p75/AIRM1. (2003) (7)
The structure of the antigen-binding site of immunoglobulins and T-cell receptors. (1995) (7)
A human TCR-Ig chimeric protein used to generate a TCR α chain variable region-specific mAb☆ (1990) (6)
A soluble form of the human CD8 alpha chain expressed in the baculovirus system: biochemical characterization and binding to MHC class I. (1993) (6)
Pre–T-cell receptor binds MHC: Implications for thymocyte signaling and selection (2015) (6)
Structural features of the full-length adaptor protein GADS in solution determined using small-angle X-ray scattering. (2008) (6)
Preliminary crystallographic study of the Fab fragment of a monoclonal anti-phenylarsonate antibody possessing a major idiotypic specificity. (1983) (6)
Dual conformations of a T cell receptor Vα homodimer: implications for variability in VαVβ domain association 1 1Edited by I. A. Wilson (1997) (6)
Crystallization and preliminary X-ray diffraction study of an idiotope-anti-idiotope Fv-Fv complex. (1994) (5)
A Positive Cooperativity Binding Model between Ly49 Natural Killer Cell Receptors and the Viral Immunoevasin m157 (2013) (5)
Superantigen Recognition by γδ T Cells (2001) (5)
CRYSTAL STRUCTURE OF HUMAN CD69 (2000) (5)
Crystallization and preliminary X-ray diffraction studies of antigen--antibody complexes. (1988) (4)
Antigenicity and Immunogenicity of Differentially Glycosylated HCV E2 Envelope Proteins Expressed in Mammalian and Insect Cells (2019) (4)
Cooperative binding of T cell receptor and CD4 to peptide-MHC enhances antigen sensitivity (2022) (3)
A positive cooperativity binding model between Ly49 natural killer cell receptors and the viral immunoevasin m157. KINETIC AND THERMODYNAMIC STUDIES. (2015) (3)
Structure of a superantigen T-cell receptor chain complex (1996) (3)
CHAPTER 31 – Antibody Structure and Recognition of Antigen (2004) (3)
Cooperative binding of TCR and CD4 to pMHC enhances TCR sensitivity (2021) (3)
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate (2022) (3)
Crystal structure of human peptidoglycan recognition protein (PGRP-S) (2005) (3)
The crystal structure of Ly49C bound to H-2Kb (2008) (3)
Cloning, expression, and crystallization of the Vδ domain of a human γδ T‐cell receptor (1996) (3)
X-ray diffraction studies of an anti-azophenylarsonate antibody and of an antigen-antibody complex. (1985) (3)
Human class II MHC protein HLA-DR1 bound to a designed peptide related to influenza virus hemagglutinin, FVKQNA(MAA)AL, in complex with staphylococcal enterotoxin C3 variant 3B2 (SEC3-3B2) (2003) (2)
Crystal Structure of the Ly 49 I Natural Killer Cell Receptor Reveals Variability in Dimerization Mode within the Ly 49 Family (2002) (2)
Haplotype Multiple Sclerosis-Associated HLA-DR 2 of the HLA-DR and-DQ Molecules in the Redundancy in Antigen-Presenting Function (2006) (2)
Structure of the F-spondin domain of mindin (2009) (2)
Crystallization and preliminary X-ray diffraction study of a bacterially produced T-cell antigen receptor V alpha domain. (1994) (2)
Engineering High-Affinity T Cell Receptor/ Cytokine Fusions for Therapeutic Targeting (2012) (2)
Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors (2021) (1)
A growing family of natural killers. (2003) (1)
Kinetic and thermodynamic studies of the interaction between activating and inhibitory Ly49 natural killer receptors and MHC class I molecules. (2017) (1)
Editorial overview: Engineering and design (2022) (1)
Receptor Ly 49 A on Living Cells Mapping the Ligand of the NK Inhibitory (2000) (1)
How Natural Killer Cell Receptors Stick to Cell-Cell Adhesion Proteins. (2019) (1)
T cell receptors employ diverse strategies to target a p53 cancer neoantigen (2022) (1)
Epitope Mapping of Therapeutic Antibodies Targeting Human LAG3 (2022) (1)
Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor G4 (2012) (1)
Studies of structure and specificity of some antigen-antibody complexes. (1989) (1)
Natural Killer Cell Receptors (2018) (1)
Crystal structure of Fab fragment of antibody HyHEL-8 complexed with its antigen lysozyme (2003) (1)
Identification of Endoplasmic Reticulum α-Glucosidase I from a Thermophilic Fungus as a Platform for Structure-Guided Antiviral Drug Design. (2022) (1)
Distinct features of human CD8 T cell TCR repertoire specific to influenza A virus matrix protein M1 (2016) (1)
Three-Dimensional Structure and Specificity of Monoclonal Antilysozyme Antibodies (1986) (1)
Crystal Structure of Staphylococcal Enterotoxin G (SEG) in Complex with a High Affinity Mutant Mouse T-cell Receptor Chain (2010) (0)
Engineering T cell receptors for potential therapeutic applications (48.28) (2007) (0)
Structure of NK cell receptor 2B4 (CD244) bound to its ligand CD48 (2007) (0)
Crystal structure of a gp100:44-59 peptide-HLA-DR4 complex enables design of an altered peptide ligand with enhanced immunogenicity (100.25) (2010) (0)
Crystal structure of Fab fragment of antibody HyHEL-26 complexed with lysozyme (2003) (0)
IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX (1996) (0)
T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SEB (1999) (0)
Fab Fragment of Anti-human LAG3 antibody (BAP050) (0)
NMR structure of the D1 domain of the Natural Killer Cell Receptor, 2B4 (2005) (0)
SARS-CoV-2 RLQ peptide-specific TCR pRLQ3 (2021) (0)
Phospholipase Cgamma1 SH3 in complex with a SLP-76 motif (2005) (0)
Crystallographic study of the complex between the Fab fragment of monoclonal anti-lysozyme antibody and its antigen (1984) (0)
Crystal structure of variable lymphocyte receptor VLRA.R5.1 (2010) (0)
Fine Specificity of Monoclonal Anti-Lysozyme Antibodies and the Three-Dimensional Structure of a Lysozyme-Antibody Complex (1987) (0)
Molecular Recognition in the Immune System (2005) (0)
Crystallization and preliminary X-ray diffraction analysis of the beta-chain of a T-cell antigen receptor. (1994) (0)
I-107 Long-range allosteric effects induced by Tax–HLA-A2 binding to an anti-HTLV-1 TCR: Implications for early T cell signaling (2019) (0)
VARIABLE DOMAIN OF T CELL RECEPTOR DELTA CHAIN (1998) (0)
Crystal structure of HLA-DR1/TPI(23-37) complexed with staphylococcal enterotoxin C3 variant 3B2 (SEC3-3B2) (2002) (0)
Crystal Structure of a Bivalent Antibody Fab Fragment. (2020) (0)
Phospholipase Cgamma1 SH3 (2005) (0)
Allosteric Effects and Signal Transduction in the Peptide-MHC Binding to a Human T Cell Receptor (2019) (0)
The crystal structure of Fab NQ10 (1987) (0)
Crystal structure of human CD4 complexed with MHC class II, peptide and T cell receptor (100.47) (2011) (0)
T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN (1997) (0)
Crystal structure of of the SH3 domain of phospholipase C Gamma-1 (2006) (0)
TCR F50 recgonizing M1-HLA-A2 (2017) (0)
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors (2022) (0)
Crystal structure of a complex between B7-H6, a tumor cell ligand for natural cytotoxicity receptor NKp30, and an inhibitory antibody (2016) (0)
Crystal structure of human CD4 complexed with MHC class II, peptide and T cell receptor (2011) (0)
Structure of NK cell receptor 2B4 (CD244) (2007) (0)
Crystal structure of 3A6 TCR bound to MBP/HLA-DR2a (2005) (0)
Fab Fragment of Anti-human LAG3 antibody (22D2) (0)
Complex of HLA-A2, a class I MHC, with a p53 peptide (2020) (0)
Crystal Structure of the G17E/A52V/S54N/K66E/Q72H/E80V/L81S/T87S/G96V variant of the murine T cell receptor V beta 8.2 domain (2006) (0)
SARS-CoV-2 RLQ peptide-specific TCR pRLQ3 binds to RLQ-HLA-A2 (2021) (0)
CRYSTAL STRUCTURE OF A VARIABLE DOMAIN MUTANT OF A T-CELL RECEPTOR ALPHA CHAIN (1998) (0)
Recognition of the BG-H Antigen by a Lamprey Variable Lymphocyte Receptor (2013) (0)
Crystal structure of a human autoimmune TCR MS2-3C8 bound to MHC class II self-ligand MBP/HLA-DR4 (2011) (0)
Antibody-antigen recognition: the structure of a Fab-lysozyme complex (1987) (0)
T cell receptor beta chain complexed with superantigen SpeA soaked with zinc (2002) (0)
Crystal structure of a CDR3 mutant of a T cell antigen receptor Va domain (1996) (0)
Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity (2023) (0)
Crystal structure of T-cell receptor V beta domain variant complexed with superantigen SEC3 mutant (2006) (0)
Crystal Structure of Lampetra planeri VLRC (2015) (0)
T cell receptor bias for MHC: co-evolution or co-receptors? (2014) (0)
SARS-CoV-2 YLQ peptide-specific TCR pYLQ7 (2021) (0)
Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM (2016) (0)
Crystal Structure of HyHEL-63 complexed with HEL mutant K96A (2003) (0)
SARS-CoV-2 RLQ peptide binds to HLA-A2 (2021) (0)
The crystal structure of natural killer cell receptor Ly49C (2008) (0)
CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63 (2000) (0)
Structure for antibody HyHEL-63 Y33A mutant complexed with hen egg lysozyme (2005) (0)
Fab Fragment of Anti-human LAG3 antibody (4A10) (2021) (0)
Molecular recognition of the natural killer cell receptors 2B4 and Ly49 with their respect ligands (2008) (0)
Cloning, expression, and crystallization of the VS domain of a human y6 T-cell receptor (1996) (0)
Crystal structure of HLA-DR1/TPI(23-37, Thr28-->Ile mutant) complexed with staphylococcal enterotoxin C3 variant 3B2 (SEC3-3B2) (2002) (0)
Crystal Structure of Staphylococcal Enterotoxin G (SEG) in Complex with a Mouse T-cell Receptor Î2 Chain* (2020) (0)
Crystal structure of human PGRP-IalphaC in complex with muramyl pentapeptide (2006) (0)
Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the Superantigen SEC3 Variant 3B1 (2003) (0)
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2 (2016) (0)
Crystal structure of an autoimmune TCR with optimal binding to its self-antigen - an alternative strategy for escaping negative selection (93.32) (2010) (0)
B Cell Responses and Control of HCV Infection (2016) (0)
Biophysical Properties of Immune Receptor Proteins at the Membrane Interface (2014) (0)
II / Superantigen / TCR Ternary Complexes Further Diversity in MHC Class of Toxic Shock Syndrome Toxin-1 Predicts Functional Analysis of the TCR Binding Domain (2003) (0)
Crystal Structure of Staphylococcal Enterotoxin G (2006) (0)
Faculty of 1000 evaluation for Monomeric TCRs drive T cell antigen recognition. (2018) (0)
Crystal Structure of HyHEL-63 complexed with HEL mutant K97A (2003) (0)
Crystal structure of the C-terminal PGN-binding domain of human PGRP-Ialpha in complex with PGN analog muramyl tripeptide (2004) (0)
Crystal structure of variable lymphocyte receptor VLRA.R2.1 in complex with hen egg lysozyme (2010) (0)
Long-range effects induced by peptide-MHC binding to a human T cell receptor: Implications for the initiation of T cell signaling (2018) (0)
Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26 (2016) (0)
Energetic and structural basis of sialylated oligosaccharide recognition by the natural killer cell inhibitory receptor p75/AIRM1 or Siglec-7 (2003) (0)
CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A) (2000) (0)
Structure of NK cell receptor ligand CD48 (2007) (0)
Structure of NK cell receptor KLRG1 bound to E-cadherin (2009) (0)
Complex of Streptococcal pyrogenic enterotoxin C (SpeC) with a human T cell receptor beta chain (Vbeta2.1) (2002) (0)
Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity. (2023) (0)
Binding Energetics in Antigen–Antibody Interfaces (2010) (0)
T cell receptor-p53-HLA-A2 complex (2020) (0)
16 – Structural Basis of Antigen–Antibody Recognition (1990) (0)
Structure of a lamprey variable lymphocyte receptor (2009) (0)
A human TCR-Ig chimeric protein used to generate a TCR alpha chain variable region-specific mAb. (1990) (0)
Table of Contents (1990) (0)
CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY (2000) (0)
X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2Kb (2003) (0)
Crystal structure of NK receptor Ly49C mutant with its MHC class I ligand H-2Kb (2003) (0)
Crystal structure of Fab fragment of Anti-HCV E2 antibody (HC84.26) (2020) (0)
HEN EGG WHITE LYSOZYME, D18A MUTANT, IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3 (1998) (0)
Structure of NK cell receptor KLRG1 (2009) (0)
p53-specific T cell receptor (2020) (0)
SARS-CoV-2 YLQ peptide binds to HLA-A2 (2021) (0)
Multiple Sclerosis-Associated HLA-DR2 of the HLA-DR and -DQ Molecules in the Redundancy in Antigen-Presenting Function (2006) (0)
FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME (1996) (0)
Heterogeneous Immunogenicity Restricted Peptide Ligands with - Class II Structure-Based Design of Altered MHC (2014) (0)
CHAPTER 7 – Binding Energetics in Antigen–Antibody Interfaces (2003) (0)
Crystal structure of anti-HCV E2 antibody HC84-26 (2016) (0)
Crystal structure of TCR C7 in complex with HCMV NLV epitope presented by HLA-A2 (2015) (0)
Structure of MHC class II molecule HLA-DR1 complexed with phosphopeptide MART-1 (2010) (0)
SARS-CoV-2 YLQ peptide-specific TCR pYLQ7 binds to YLQ-HLA-A2 (2021) (0)
Recognition of the Thomsen-Friedenreich Antigen by a Lamprey Variable Lymphocyte Receptor (2013) (0)
Self recognition in the immune system: structure of a Natural Killer receptor bound to its MHC class I ligand (2000) (0)
Fab Fragment of Anti-human LAG3 antibody (13E2) (0)
Complex between NK cell receptor Ly49A and its MHC class I ligand H-2Dd (2000) (0)
Crystal Structure of the S54N variant of murine T cell receptor Vbeta 8.2 domain (2006) (0)
MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN IMMUNODOMINANT PEPTIDE P18-I10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120 (1999) (0)
TCR beta chain complexed with streptococcal superantigen SpeA (2002) (0)
Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen (2020) (0)
Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida (2018) (0)
Crystal structure of C25-NLV-HLA-A2 complex (2015) (0)
STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1 (2015) (0)
Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR (2007) (0)
Crystal Structure of the A52V/S54N/K66E variant of the murine T cell receptor V beta 8.2 domain (2006) (0)
Co-crystal structure of alpha glucosidase with compound 10 (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roy A. Mariuzza?

Roy A. Mariuzza is affiliated with the following schools:

University of Maryland, College Park
University of Tennessee
Bowie State University
University of Copenhagen
University of Georgia

Roy A. Mariuzza's Academic­Influence.com Rankings

Roy A. Mariuzza's Degrees

Why Is Roy A. Mariuzza Influential?

Roy A. Mariuzza's Published Works

Published Works

What Schools Are Affiliated With Roy A. Mariuzza?

Roy A. Mariuzza's AcademicInfluence.com Rankings